BioCentury
ARTICLE | Company News

Supernus deal

January 9, 2012 8:00 AM UTC

Neurology company Supernus raised $42 million in December. The amount comprises $15 million in venture debt and $27 million from the sale of its TCD Royalty LLC subsidiary to Royalty Opportunities S.a...